Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™ (PPMI Early Imaging)

NCT04507139 is registered in ClinicalTrials.gov with Michael J. Fox Foundation for Parkinson's Research as lead sponsor.

NCT NCT04507139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04507139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™ (PPMI Early Imaging)
Lead sponsor
Michael J. Fox Foundation for Parkinson's Research
Phase
Observational
Overall status
Active, not recruiting
Start date
September 10, 2020
Completion date
June 30, 2025
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease